Few data are available on hospital-wide incidence of central line–associated bloodstream infection (CLABSI) rates in patients with central venous catheter (CVC) in China, where many systemic obstacles holding back evidence-based guidelines implementation exist” Han et al (2019).
Background: Few data are available on hospital-wide incidence of central line–associated bloodstream infection (CLABSI) rates in patients with central venous catheter (CVC) in China, where many systemic obstacles holding back evidence-based guidelines implementation exist.
Methods: This study was conducted prospectively in 2 phases. The baseline and intervention phases were performed in a teaching hospital in China, between January 2017 and October 2018. A systematic quality improvement (SQI) and multidisciplinary teamwork (MDT) CLABSI infection control program was introduced in the intervention phase. In the intensive care units (ICUs) and non-ICUs, CLABSIs were continuously monitored, data collected, then analyzed.
Results: After intervention, the CLABSI rate decreased from 2.84-0.56 per 1,000 CVC days in ICUs (P < .001), and from 0.82-0.47 per 1,000 CVC days in non-ICUs (P = .003). The length of time until CLABSI occurrence increased from 8.72-13.60 days in ICUs (P = .046), and from 10.00-12.00 days in non-ICUs (P = .048). The number of multidrug-resistant bacteria isolated from CLABSI episodes decreased both in ICUs and in non-ICUs. Conclusions: The SQI and MDT CLABSI infection control program is effective in reducing hospital-wide CLABSI in patients with CVC, both in ICUs and in non-ICUs.
You may also be interested in…
Han, J., Wan, J., Cheng, Y., Li, D., Deng, M., Wang, X., Feng, J., He, Y., Ye, Q., Wang, L., Lei, Y. and Wang, J. (2019) A hospital-wide reduction in central line–associated bloodstream infections through systematic quality improvement initiative and multidisciplinary teamwork. American Journal of Infection Control. July 2nd. DOI: https://doi.org/10.1016/j.ajic.2019.05.008. .